Medication info
Janugrine 50 mg (Sitagliptin Hydrochloride Monohydrate)

Janugrine 50 mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›56.7mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
Light yellow-pink round biconvex film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP×3]
Approval status
Active

MFDS item code 202005911 · Approved 2020.08.20 · Insurance code 650304350

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer 100 mg once daily as monotherapy or combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Because dose adjustment according to renal function is required, assessment of renal function is recommended before starting this medicine and periodically during treatment. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty in blood sugar control
View approved original text

This medication is used in combination with diet and exercise to assist with blood sugar control in patients with type 2 diabetes. It can be administered as monotherapy but, if a patient has never taken diabetes medication before and finds blood sugar control difficult with monotherapy, it can be used in combination with metformin. Additionally, when sufficient blood sugar control is difficult with monotherapy using sulfonylureas, metformin, thiazolidinediones, or insulin, this medication can also be used in combination. It helps improve blood sugar management even when control is difficult with a combination of several medications, contributing effectively to blood sugar control tailored to various treatment conditions.

How to take

Adult dose

Administer 100 mg once daily as monotherapy or combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Because dose adjustment according to renal function is required, assessment of renal function is recommended before starting this medicine and periodically during treatment. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may cause allergic reactions, so if symptoms such as skin rash or difficulty breathing occur within three months after initial use, discontinue immediately and consult a doctor. Serious inflammation of the pancreas known as pancreatitis may occur while taking this medication, so if symptoms like abdominal pain, vomiting, or fever arise, notify the healthcare professional immediately. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication, nor should those who are allergic to this medication or its components. Patients with impaired kidney function may have delayed drug elimination, necessitating dosage adjustments and regular kidney function tests. Side effects may include upper respiratory infection, headache, rhinitis, dyspepsia, diarrhea, nausea, etc., and particularly when taken with insulin or sulfonylureas, there is an increased risk of hypoglycemia. In the event of hypoglycemic symptoms, blood sugar should be checked immediately and appropriate measures taken if necessary, and insulin or sulfonylurea doses may need adjustment to reduce the risk of hypoglycemia. This medication may cause serious skin conditions such as arthralgia or bullous pemphigoid, so consult a doctor immediately if such symptoms occur. Pregnant or breastfeeding women are advised against taking this medication, and safety has not been established for children or adolescents under 18 years of age. This medication generally has few drug interactions, but it is important to closely monitor blood concentration changes if taken with cyclosporine or digoxin. In cases of overdose, appropriate treatments such as gastrointestinal decontamination and electrocardiogram monitoring should be performed, with hemodialysis considered for removing some of the medication if necessary. Elderly patients may have increased likelihood of reduced kidney function, hence dosage adjustments and regular kidney function testing are necessary, and regular health evaluations during medication use are recommended.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 27 more
  • nausea
  • constipation
  • vomiting
  • rash
  • urticaria
  • cutaneous vasculitis
  • severe and disabling arthralgia
  • blistering similar to pemphigus
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased blood triglycerides
  • gastritis
  • severe hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent air ingress, and keep at room temperature between 1 to 30 degrees Celsius. This helps maintain the efficacy of the medication and prevents degradation.

Appearance and packaging

Appearance

Light yellow-pink round biconvex film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP×3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.